Login to Your Account



Cellzome Lands EUR30M Financing For Programs In Drug Discovery

By Douglas Merrill


Wednesday, March 26, 2003
Cellzome AG bucked the gloomy venture market and raised €30 million in its third round of financing. The company, spun off from the European Molecular Biology Laboratory in Heidelberg in May 2000, aims to speed and streamline drug discovery through better understanding the role of cellular pathways in human diseases. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription